Innovative BioTherapies to help soldiers heal, create jobs

There isn’t much about Innovative BioTherapies that isn’t a feel-good story. It makes a product that helps save combat soldiers’ lives, hopes to transfer that technology to every day medicine while it looks to create a few jobs (and maybe even hire former Pfizer worker or two).

Getting your Trinity Audio player ready...

It’s been a quick rise to the top for Innovative BioTherapies. The University of Michigan spin-off started with just its founder, U-M Prof. David Hume, in 2003 and now employs 16 people with plans to hire a couple more.

 

The firm specializes in bio-artificial kidneys, which have been used extensively in combat operations in Iraq. Field hospitals use the technology to help provide quick relief for kidneys, helping to prevent septus and kidney failure while doctors work their magic.

 

The combination of polymers, cells and biomaterials could also have applications in every day medicine with possible applications for diabetes patients. Innovative BioTherapies is looking into exploring those possibilities but company spokeswoman Deb Buffington says the diabetes angle is still years away from becoming reality.

 

In the meantime, the company has increased its research staff, hiring one former Pfizer employee and possibly adding another in the near future. 
 

Source: Deb Buffington, vice president of Innovative BioTherapies
Writer: Jon Zemke

Author

Our Partners

30044
30045
30046
30047
30049
Washtenaw ISD logo
Eastern Michigan University
Ann Arbor Art Center
UMS
U of M Arts Initiative
Engage EMU

Common Ground Is Brewing

Support local stories and receive our signature roast straight to your door when you join at the Standard level (or above).

Drink Better, Read Local

Close the CTA

Don't miss out!

Everything Ann Arbor and Ypsilanti, in your inbox every week.

Close the CTA

Already a subscriber? Enter your email to hide this popup in the future.